KOPRAN
|
KOPRAN Last 5 Year Cashflow Statement History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit Before Tax | ₹52 Cr | ₹68 Cr | ₹36 Cr | ₹82 Cr | ₹83 Cr |
Adjustment | ₹25 Cr | ₹21 Cr | ₹16 Cr | ₹14 Cr | ₹16 Cr |
Changes In working Capital | ₹-22 Cr | ₹-31 Cr | ₹-5.55 Cr | ₹-111 Cr | ₹-24 Cr |
Cash Flow after changes in Working Capital | ₹55 Cr | ₹58 Cr | ₹47 Cr | ₹-15 Cr | ₹76 Cr |
Cash Flow from Operating Activities | ₹42 Cr | ₹43 Cr | ₹34 Cr | ₹-33 Cr | ₹60 Cr |
Cash Flow from Investing Activities | ₹-56 Cr | ₹-44 Cr | ₹-13 Cr | ₹-84 Cr | ₹-25 Cr |
Cash Flow from Financing Activities | ₹26 Cr | ₹0.99 Cr | ₹-20 Cr | ₹123 Cr | ₹-35 Cr |
Net Cash Inflow / Outflow | ₹11 Cr | ₹0.69 Cr | ₹1.53 Cr | ₹4.93 Cr | ₹0.10 Cr |
Opening Cash & Cash Equivalents | ₹8.09 Cr | ₹7.40 Cr | ₹5.87 Cr | ₹0.94 Cr | ₹0.83 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹19 Cr | ₹8.09 Cr | ₹7.40 Cr | ₹5.87 Cr | ₹0.94 Cr |
Compare Cashflow Statement of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹810.2 Cr | 0.7% | -3.3% | -44.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,140.0 Cr | 2.1% | 2.4% | -11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,290.0 Cr | 0.7% | 8.2% | 8.1% | Stock Analytics | |
CIPLA | ₹132,417.0 Cr | 5.6% | 3.9% | 1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,839.0 Cr | 1.5% | 0.1% | 1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,031.0 Cr | 3.7% | -3% | -6.4% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | 0.7% |
-3.3% |
-44.5% |
SENSEX | 2.5% |
2% |
3.1% |
You may also like the below Video Courses